Impact of the COVID-19 Pandemic on Health Check-ups: A Nationwide Questionnaire Survey in 639 Healthcare Facilities in Japan Society of Ningen Dock

Overview

Journal JMA J

Specialty General Medicine

Date 2023 Aug 10

PMID 37560372

Authors

Satoko Yamaguchi

Tomofumi Atarashi

Akira Okada

Shigeru Nasu

Toshimasa Yamauchi

Yasuji Arase

Takao Aizawa

Masaomi Nangaku

Takashi Kadowaki

Affiliations

Soon will be listed here.

Abstract

Introduction: Health check-ups have been disrupted worldwide by the COVID-19 pandemic, especially at its beginning. In Japan, undergoing annual check-ups is mandatory for full-time employees of all ages, while those other than full-time employees are entitled to undergo nonmandatory cancer screenings and specific health check-ups. To evaluate the impact of the COVID-19 pandemic on health check-ups, we conducted a nationwide questionnaire survey targeting healthcare facilities.

Methods: A questionnaire survey was conducted between December 10, 2021, and January 28, 2022. Healthcare facilities were eligible if they were members of Japan Society of Ningen Dock and could respond via email. The monthly and yearly numbers of examinees undergoing mandatory or nonmandatory check-ups in 2020 and 2021 were compared with those in 2019. The proportions of examinees requiring follow-up visits and adhering to follow-up visits were compared between 2020 and 2019. Precautions taken against COVID-19 were also investigated.

Results: Of the 1,299 eligible facilities, 639 participated (response rate, 49.2%). Health check-up services were suspended in 484 (75.7%) facilities for a median duration of 5 (interquartile range [IQR]: 4-8) weeks. A total of 19,861,230 and 21,748,125 examinees underwent health check-ups in 591 facilities in 2020 and 2021, respectively, 10.0% and 1.4% less than the numbers in 2019. The number of examinees undergoing health check-ups decreased by a median of 8.3% (IQR: -14.6 to -3.1) in 2020 compared to that in 2019, with the largest decrease of 70.3% (IQR -87.9 to -48.5) in May. Although the number of examinees undergoing mandatory check-ups increased in 2021 compared with that in 2019, the number of those undergoing nonmandatory check-ups remained low.

Conclusions: While people eligible for mandatory check-ups were adherent to check-ups in 2021, those ineligible for mandatory check-ups seemed less adherent. Public health efforts to encourage these people to adhere to check-ups during the pandemic are required.

Citing Articles

Change in Breast Cancer Screening Participation during COVID-19 Based on the 2019 and 2022 Comprehensive Survey of Living Conditions in Japan.

Kawamura C, Iwagami M, Komiyama J, Taniguchi Y, Sun Y, Masuda R JMA J. 2025; 8(1):183-190.

PMID: 39926056 PMC: 11799596. DOI: 10.31662/jmaj.2024-0234.

Association of laughter and social communication with oral frailty among residents in Fukushima: a cross-sectional study.

Funakubo N, Okazaki K, Hayashi F, Eguchi E, Nishimagi M, Nakano H Sci Rep. 2024; 14(1):26818.

PMID: 39500960 PMC: 11538540. DOI: 10.1038/s41598-024-77966-7.

Impact of the COVID-19 pandemic on short-term outcomes after pancreaticoduodenectomy for pancreatic cancer: A retrospective study from the Japanese National Clinical Database, 2018-2021.

Takemura Y, Endo H, Hibi T, Nakano Y, Seishima R, Takeuchi M Ann Gastroenterol Surg. 2024; 8(5):877-887.

PMID: 39229557 PMC: 11368487. DOI: 10.1002/ags3.12798.

Association of Inflammatory Bowel Disease with Incident IgA Nephropathy.

Nakayama T, Kaneko H, Okada A, Suzuki Y, Fujiu K, Takeda N Clin J Am Soc Nephrol. 2024; 19(6):704-711.

PMID: 38600627 PMC: 11168824. DOI: 10.2215/CJN.0000000000000457.

Modification effect of receipt of diabetes care on the association between COVID-19 infection and HbA1c level during the first year of the coronavirus pandemic using a nationwide population-based database.

Okada A, Yamaguchi S, Ono S, Kurakawa K, Yasunaga H, Nangaku M J Diabetes Investig. 2024; 15(7):953-963.

PMID: 38429979 PMC: 11215684. DOI: 10.1111/jdi.14171.

References

Duffy S, Seedat F, Kearins O, Press M, Walton J, Myles J . The projected impact of the COVID-19 lockdown on breast cancer deaths in England due to the cessation of population screening: a national estimation. Br J Cancer. 2022; 126(9):1355-1361. PMC: 8808468. DOI: 10.1038/s41416-022-01714-9. View

Tsushita K, Hosler A, Miura K, Ito Y, Fukuda T, Kitamura A . Rationale and Descriptive Analysis of Specific Health Guidance: the Nationwide Lifestyle Intervention Program Targeting Metabolic Syndrome in Japan. J Atheroscler Thromb. 2017; 25(4):308-322. PMC: 5906184. DOI: 10.5551/jat.42010. View

Carr M, Wright A, Leelarathna L, Thabit H, Milne N, Kanumilli N . Impact of COVID-19 on diagnoses, monitoring, and mortality in people with type 2 diabetes in the UK. Lancet Diabetes Endocrinol. 2021; 9(7):413-415. PMC: 8112824. DOI: 10.1016/S2213-8587(21)00116-9. View

Maringe C, Spicer J, Morris M, Purushotham A, Nolte E, Sullivan R . The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study. Lancet Oncol. 2020; 21(8):1023-1034. PMC: 7417808. DOI: 10.1016/S1470-2045(20)30388-0. View

Lu J . Ningen Dock: Japan's unique comprehensive health checkup system for early detection of disease. Glob Health Med. 2022; 4(1):9-13. PMC: 8884042. DOI: 10.35772/ghm.2021.01109. View

Fedewa S, Star J, Bandi P, Minihan A, Han X, Yabroff K . Changes in Cancer Screening in the US During the COVID-19 Pandemic. JAMA Netw Open. 2022; 5(6):e2215490. PMC: 9166223. DOI: 10.1001/jamanetworkopen.2022.15490. View

Kohro T, Furui Y, Mitsutake N, Fujii R, Morita H, Oku S . The Japanese national health screening and intervention program aimed at preventing worsening of the metabolic syndrome. Int Heart J. 2008; 49(2):193-203. DOI: 10.1536/ihj.49.193. View

Chen R, Haynes K, Du S, Barron J, Katz A . Association of Cancer Screening Deficit in the United States With the COVID-19 Pandemic. JAMA Oncol. 2021; 7(6):878-884. PMC: 8085759. DOI: 10.1001/jamaoncol.2021.0884. View

Holland D, Heald A, Stedman M, Hanna F, Wu P, Duff C . Assessment of the effect of the COVID-19 pandemic on UK HbA1c testing: implications for diabetes management and diagnosis. J Clin Pathol. 2021; 76(3):177-184. DOI: 10.1136/jclinpath-2021-207776. View

10.

Bakouny Z, Paciotti M, Schmidt A, Lipsitz S, Choueiri T, Trinh Q . Cancer Screening Tests and Cancer Diagnoses During the COVID-19 Pandemic. JAMA Oncol. 2021; 7(3):458-460. PMC: 7809614. DOI: 10.1001/jamaoncol.2020.7600. View

11.

Yamaguchi S, Okada A, Sunaga S, Kurakawa K, Yamauchi T, Nangaku M . Impact of COVID-19 pandemic on healthcare service use for non-COVID-19 patients in Japan: retrospective cohort study. BMJ Open. 2022; 12(4):e060390. PMC: 9058318. DOI: 10.1136/bmjopen-2021-060390. View

12.

Hsieh Y, Yen C, Wu C, Wang P . Nonattendance at Scheduled Appointments in Outpatient Clinics Due to COVID-19 and Related Factors in Taiwan: A Health Belief Model Approach. Int J Environ Res Public Health. 2021; 18(9). PMC: 8122706. DOI: 10.3390/ijerph18094445. View

13.

Park A, Zhong S, Yang H, Jeong J, Lee C . Impact of COVID-19 on physical activity: A rapid review. J Glob Health. 2022; 12:05003. PMC: 8979477. DOI: 10.7189/jogh.12.05003. View

14.

Decker K, Feely A, Bucher O, Singh H, Turner D, Lambert P . Evaluating the impact of the COVID-19 pandemic on cancer screening in a central Canadian province. Prev Med. 2022; 155:106961. PMC: 8769532. DOI: 10.1016/j.ypmed.2022.106961. View

15.

Yan Y, Tomooka K, Naito T, Tanigawa T . Decreased number of inpatients with community-acquired pneumonia during the COVID-19 pandemic: A large multicenter study in Japan. J Infect Chemother. 2022; 28(5):709-713. PMC: 8776425. DOI: 10.1016/j.jiac.2022.01.013. View

16.

Nogami Y, Makabe T, Komatsu H, Kawana K, Okamoto A, Mikami M . Impact of COVID-19 on cervical cancer screening in Japan: A survey of population-based screening in urban Japan by the Japan Society of Gynecologic Oncology. J Obstet Gynaecol Res. 2021; 48(3):757-765. DOI: 10.1111/jog.15130. View

17.

de Jonge L, Worthington J, van Wifferen F, Iragorri N, Peterse E, Lew J . Impact of the COVID-19 pandemic on faecal immunochemical test-based colorectal cancer screening programmes in Australia, Canada, and the Netherlands: a comparative modelling study. Lancet Gastroenterol Hepatol. 2021; 6(4):304-314. PMC: 9767453. DOI: 10.1016/S2468-1253(21)00003-0. View

18.

Miller M, Meneveau M, Rochman C, Schroen A, Lattimore C, Gaspard P . Impact of the COVID-19 pandemic on breast cancer screening volumes and patient screening behaviors. Breast Cancer Res Treat. 2021; 189(1):237-246. PMC: 8145189. DOI: 10.1007/s10549-021-06252-1. View